Cargando…

Long-Term Effectiveness, Safety, and Patient-Reported Outcomes of Self-Administered Subcutaneous Hepatitis B Immunoglobulin in Liver Post-Transplant Hepatitis B Prophylaxis: A Prospective Non-Interventional Study

BACKGROUND: Self-administered subcutaneous hepatitis B immunoglobulin (s.c. HBIg) in combination with nucleos(t)ide analogs (NUCs) has proved to be effective and safe in preventing hepatitis B virus (HBV) reinfection after liver transplantation. MATERIAL/METHODS: This non-interventional, prospective...

Descripción completa

Detalles Bibliográficos
Autores principales:	Roche, Bruno, Bauhofer, Artur, Bravo, Miguel Ãngel Gomez, Pageaux, Georges Philippe, Zoulim, Fabien, Otero, Alejandra, Prieto, Martin, Baliellas, Carmen, Samuel, Didier
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	International Scientific Literature, Inc. 2022
Materias:	Original Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9107284/ https://www.ncbi.nlm.nih.gov/pubmed/35534995 http://dx.doi.org/10.12659/AOT.936162

Ejemplares similares

Recurrence of Hepatitis B Infection in Liver Transplant Patients Receiving Long-Term Hepatitis B Immunoglobulin Prophylaxis
por: Beckebaum, Susanne, et al.
Publicado: (2018)

Is Hepatitis B Immunoglobulin Necessary in Prophylaxis of Hepatitis B Recurrence after Liver Transplantation? A Meta-Analysis
por: Wang, Peijie, et al.
Publicado: (2014)

Determination of Hepatitis B Immunoglobulin Infusion Interval Using Pharmacokinetic Half-life Simulation for Posttransplant Hepatitis B Prophylaxis
por: Hwang, Shin, et al.
Publicado: (2019)

Hepatitis B immunoglobulin prophylaxis for de novo hepatitis B infection in liver transplantation: a 30-year experience
por: Jung, Hye-Sol, et al.
Publicado: (2022)

Rational Basis for Optimizing Short and Long-term Hepatitis B Virus Prophylaxis Post Liver Transplantation: Role of Hepatitis B Immune Globulin
por: Roche, Bruno, et al.
Publicado: (2015)

Innate Antiviral Immune Responses to Hepatitis B Virus
por: Ait-goughoulte, Malika, et al.
Publicado: (2010)

Meeting the Challenge of Eliminating Chronic Hepatitis B Infection
por: Revill, Peter A., et al.
Publicado: (2019)

HBVdb: a knowledge database for Hepatitis B Virus
por: Hayer, Juliette, et al.
Publicado: (2013)

Effectiveness and Safety of Tenofovir Disoproxil Fumarate in Chronic Hepatitis B: A 3-Year, Prospective, Real-World Study in France
por: Marcellin, Patrick, et al.
Publicado: (2016)

Cost-effectiveness and long-term outcomes of liver transplantation using hepatitis B core antibody-positive grafts with hepatitis B immunoglobulin prophylaxis in Korea
por: Kim, Kyeong Deok, et al.
Publicado: (2021)

Early intrahepatic recurrence of HBV infection in liver transplant recipients despite antiviral prophylaxis
por: Villeret, François, et al.
Publicado: (2023)

The Hepatitis B Virus Genotypes E to J: The Overlooked Genotypes
por: Toyé, Rayana Maryse, et al.
Publicado: (2023)

Switch from intravenous or intramuscular to subcutaneous hepatitis B immunoglobulin: effect on quality of life after liver transplantation
por: Volpes, Riccardo, et al.
Publicado: (2020)

Hepatitis B Vaccine and Immunoglobulin: Key Concepts
por: Das, Saibal, et al.
Publicado: (2019)

Serum hepatitis B virus DNA before liver transplantation correlates with HBV reinfection rate even under successful low-dose hepatitis B immunoglobulin prophylaxis
por: Yasunaka, Tetsuya, et al.
Publicado: (2011)

Preliminary Evidence for Hepatitis Delta Virus Exposure in Patients Who Are Apparently Not Infected With Hepatitis B Virus
por: Chemin, Isabelle, et al.
Publicado: (2021)

Durability of Hepatitis B Surface Antigen Loss With Nucleotide Analogue and Peginterferon Therapy in Patients With Chronic Hepatitis B
por: Lok, Anna S., et al.
Publicado: (2019)

Assessing immunological and virological responses in the liver: Implications for the cure of chronic hepatitis B virus infection
por: Boettler, Tobias, et al.
Publicado: (2022)

Antibodies against Hepatitis A and Hepatitis B Virus in Intravenous Immunoglobulin Products
por: Lee, Soyoung, et al.
Publicado: (2016)

A 6-month mixed-effect pharmacokinetic model for post-transplant intravenous anti-hepatitis B immunoglobulin prophylaxis
por: Han, Seunghoon, et al.
Publicado: (2017)

Efficacy of antepartum administration of hepatitis B immunoglobulin in preventing mother‐to‐child transmission of hepatitis B virus
por: Zhao, Mengyu, et al.
Publicado: (2019)

Misleading hepatitis B testing in the setting of intravenous immunoglobulin
por: Ilboudo, Christelle M, et al.
Publicado: (2013)

Economic Impact of European Liver and Intestine Transplantation Association (ELITA) Recommendations for Hepatitis B Prophylaxis After Liver Transplantation
por: Cortesi, Paolo Angelo, et al.
Publicado: (2023)

Maternal hepatitis B e antigen can be an indicator for antiviral prophylaxis of perinatal transmission of hepatitis B virus
por: Lu, Ying, et al.
Publicado: (2021)

Landscape of oncoviral genotype and co-infection via human papilloma and hepatitis B viral tumor in situ profiling
por: Bubie, Adrian, et al.
Publicado: (2021)

Patient adherence issues in the treatment of hepatitis C
por: Larrey, Dominique, et al.
Publicado: (2014)

Hepatitis B Immune Globulin in Liver Transplantation Prophylaxis: An Update
por: Dindoost, Payam, et al.
Publicado: (2012)

Outcomes of hepatitis B immunoglobulin and hepatitis B vaccination in high-risk newborns born to HBeAg-positive mothers
por: Wu, Chen-Hsuan, et al.
Publicado: (2022)

Outcome of Intravenous Immunoglobulin-Transmitted HTLV-I, Hepatitis B, Hepatitis C, and HIV infections
por: Foroughipour, Mohsen, et al.
Publicado: (2013)

Hepatitis B Virus Impairs TLR9 Expression and Function in Plasmacytoid Dendritic Cells
por: Vincent, Isabelle E., et al.
Publicado: (2011)

An “immune barrier” is formed in the placenta by hepatitis B immunoglobulin to protect the fetus from hepatitis B virus infection from the mother
por: Liu, Jinfeng, et al.
Publicado: (2015)

The efficiency of low-dose hepatitis B immunoglobulin plus nucleos(t)ide analogs in preventing posttransplant hepatitis B virus recurrence
por: VATANSEVER, Sezgin, et al.
Publicado: (2019)

The indications and safety of polyvalent immunoglobulin for post-exposure prophylaxis of hepatitis A, rubella and measles
por: Young, Megan K.
Publicado: (2019)

Hepatitis B Postexposure Prophylaxis in Preterm and Low-Birth-Weight Infants
por: Waitz, Markus, et al.
Publicado: (2015)

Benefits of immunoglobulin substitution in primary and secondary immunodeficiencies: Interim analysis of a prospective, long-term non-interventional study
por: Bauhofer, Artur, et al.
Publicado: (2021)

HIRA Supports Hepatitis B Virus Minichromosome Establishment and Transcriptional Activity in Infected Hepatocytes
por: Locatelli, Maëlle, et al.
Publicado: (2022)

Prophylaxis of Hepatitis B Virus (HBV) Re-Infection in Liver Transplantation: Is the Reappearance of Hepatitis B Surface Antigen (HBsAg) Significant?
por: Brancaccio, Giuseppina, et al.
Publicado: (2020)

Protective Effect of Hepatitis B Vaccine Combined with Two-Dose Hepatitis B Immunoglobulin on Infants Born to HBsAg-Positive Mothers
por: Zou, Huaibin, et al.
Publicado: (2011)

Prevention of Hepatitis B Recurrence in Liver Transplant Patients Using Oral Antiviral Therapy without Long-Term Hepatitis B Immunoglobulin
por: Ahn, Joseph, et al.
Publicado: (2011)

Efficacy of Nucleotide/Nucleoside Analogues and Hepatitis B Immunoglobulin Therapy in Blocking Mother-to-Child Transmission of Hepatitis B in an Eastern Chinese Group
por: Sun, Xiaojun, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_562eshmsncv449ksicae9nvlgb